Liabilities and Equity of U S PHYSICAL THERAPY INC /NV from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
U S PHYSICAL THERAPY INC /NV quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • U S PHYSICAL THERAPY INC /NV Liabilities and Equity for the quarter ending 31 Dec 2025 was $1,204,010,000, a 3.1% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

U S PHYSICAL THERAPY INC /NV Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,204,010,000 +$36,543,000 +3.1% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $1,196,270,000 +$167,079,000 +16% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $1,179,600,000 +$156,466,000 +15% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $1,179,687,000 +$162,431,000 +16% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $1,167,467,000 +$170,229,000 +17% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $1,029,191,000 +$19,005,000 +1.9% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $1,023,134,000 +$23,553,000 +2.4% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,017,256,000 +$149,129,000 +17% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $997,238,000 +$139,084,000 +16% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $1,010,186,000 +$210,478,000 +26% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $999,581,000 +$203,137,000 +26% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $868,127,000 +$104,264,000 +14% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $858,154,000 +$108,728,000 +15% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $799,708,000 +$169,610,000 +27% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $796,444,000 +$173,486,000 +28% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $763,863,000 +$165,473,000 +28% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $749,426,000 +$155,065,000 +26% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $630,098,000 +$54,660,000 +9.5% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $622,958,000 +$37,940,000 +6.5% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $598,390,000 -$44,863,000 -7% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $594,361,000 +$33,516,000 +6% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $575,438,000 +$10,245,000 +1.8% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $585,018,000 +$28,008,000 +5% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $643,253,000 +$120,166,000 +23% 31 Mar 2020 10-Q 21 May 2020 2020 Q1
Q4 2019 $560,845,000 +$117,679,000 +27% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $565,193,000 +$110,224,000 +24% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $557,010,000 +$116,467,000 +26% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $523,087,000 +$105,465,000 +25% 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 $443,166,000 +$24,184,000 +5.8% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 $454,969,000 +$43,982,000 +11% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $440,543,000 +$23,218,000 +5.6% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $417,622,000 +$29,951,000 +7.7% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 $418,982,000 +$67,751,000 +19% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 $410,987,000 +$76,444,000 +23% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $417,325,000 +$79,327,000 +23% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $387,671,000 +$51,928,000 +15% 31 Mar 2017 10-Q 29 Jun 2017 2017 Q1
Q4 2016 $351,231,000 +$47,474,000 +16% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 $334,543,000 +$34,572,000 +12% 30 Sep 2016 10-K 07 Jun 2017 2016 FY
Q2 2016 $337,998,000 +$45,852,000 +16% 30 Jun 2016 10-K 07 Jun 2017 2016 FY
Q1 2016 $335,743,000 +$54,494,000 +19% 31 Mar 2016 10-K 07 Jun 2017 2016 FY
Q4 2015 $303,757,000 +$59,206,000 +24% 31 Dec 2015 10-K 07 Jun 2017 2016 FY
Q3 2015 $299,971,000 +$52,234,000 +21% 30 Sep 2015 10-K 07 Jun 2017 2016 FY
Q2 2015 $292,146,000 +$51,366,000 +21% 30 Jun 2015 10-K 07 Jun 2017 2016 FY
Q1 2015 $281,249,000 +$52,615,000 +23% 31 Mar 2015 10-K 07 Jun 2017 2016 FY
Q4 2014 $244,551,000 +$20,416,000 +9.1% 31 Dec 2014 10-K 04 Mar 2016 2015 FY
Q3 2014 $247,737,000 +$68,080,000 +38% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 $240,780,000 +$58,350,000 +32% 30 Jun 2014 10-Q 07 Aug 2014 2014 Q2
Q1 2014 $228,634,000 +$51,757,000 +29% 31 Mar 2014 10-Q 09 May 2014 2014 Q1
Q4 2013 $224,135,000 +$52,421,000 +31% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 $179,657,000 +$9,717,000 +5.7% 30 Sep 2013 10-Q 07 Nov 2013 2013 Q3
Q2 2013 $182,430,000 +$11,798,000 +6.9% 30 Jun 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 $176,877,000 +$12,441,000 +7.6% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 $171,714,000 +$8,462,000 +5.2% 31 Dec 2012 10-K 11 Mar 2014 2013 FY
Q3 2012 $169,940,000 +$5,901,000 +3.6% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 $170,632,000 +$23,795,000 +16% 30 Jun 2012 10-Q/A 06 Sep 2012 2012 Q2
Q1 2012 $164,436,000 31 Mar 2012 10-Q 04 May 2012 2012 Q1
Q4 2011 $163,252,000 +$22,391,000 +16% 31 Dec 2011 10-K 12 Mar 2013 2012 FY
Q3 2011 $164,039,000 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 $146,837,000 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q4 2010 $140,861,000 31 Dec 2010 10-K 09 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.